Christina Ackermann joined the company as Executive Vice President, General Counsel, in August 2016. In this role, she is responsible for Bausch Health’s worldwide legal affairs, compliance, global security and enterprise risk management.
Prior to Bausch Health, Ackermann was part of the Novartis group of companies for 14 years, most recently serving as Senior Vice President, General Counsel for Alcon, where she was responsible for the for the legal, intellectual property and compliance functions.
Previously, she served as Global Head, Legal and General Counsel at Sandoz, the generics division of Novartis, from 2007 to 2012. She joined Novartis Pharma in 2002 as Head, Legal Technical Operations and Ophthalmics, and assumed the role of Head Legal General Medicine in July 2005.
Before Novartis, Ackermann served in Associate General Counsel roles with Bristol Myers Squibb and DuPont Pharmaceuticals, as well as in private practice, where she focused on securities, and mergers & acquisitions.
Ackermann attended York University, Toronto, Canada, for her undergraduate studies, focusing initially on fine arts and later moving into mathematics and political sciences. Ackermann also attended Queen's University, Kingston, Canada, where she obtained her LL.B., and King’s College at the University of London, UK, where she obtained a Post Graduate Diploma in EC Competition Law.
Igor Kirman is a partner in the Corporate Department at Wachtell, Lipton, Rosen & Katz, where he focuses primarily on mergers and acquisitions, activism and takeover defense, corporate governance and general corporate matters. He has advised public and private companies, as well as private equity funds, in connection with mergers and acquisitions, divestitures, leveraged buyouts, joint ventures, cross-border deals, shareholder activism, takeover de-fenses and corporate governance matters.
Mr. Kirman is a frequent speaker at professional conferences, and has written articles in numerous professional publications on topics relating to mergers and acquisitions and corporate governance. He has been frequently recognized for achievement by professional organizations such as Chambers USA, New York Superlawyers, Who’s Who Legal and Best Lawyers in America. He was twice named as Dealmaker of the Year by American Lawyer (2006 and 2015).
Mr. Kirman is the author of a book, "M&A and Private Equity Confidentiality Agreements" (Aspatore). He is the chair of the Practising Law Institute's annual "Doing Deals" program in New York and teaches a course on M&A as an adjunct at Columbia Law School. He also serves on the Advisory Board of the Practical Law Company and on the Mergers & Acquisitions Advisory Board of Strafford Publications.
Mr. Kirman received a B.A. in Ethics, Politics and Economics magna cum laude from Yale University in 1993. He completed his J.D. at Columbia Law School in 1996, where he was notes editor of the Columbia Law Review. He is involved in a number of civic institutions, and serves as a member of the Advisory Board of the Mount Sinai School of Medicine and as a Trustee of the Trinity School. He was born in Ukraine and speaks Russian.
Jane Greyf, a corporate partner in Latham & Watkins’ New York office, advises private equity firms and their portfolio companies in a range of corporate transactions. She also advises corporate clients in strategic M&A matters.
Ms. Greyf helps clients maximize the value of their corporate transactions. A member of the Mergers & Acquisitions Practice, she represents leveraged buyout sponsors, venture capital funds, hedge funds, and other private equity investors and portfolio companies. She brings to clients a keen market perspective on transactions including:
She also represents public and private companies in connection with corporate governance, securities law compliance, and general corporate matters.
Mr. Greyf's experience spans the energy, general industrials, and technology sectors, among other industries. Her extensive track record of M&A and private equity work includes representing:
*Matter handed prior to joining Latham
Kevin Miller is a partner in the Corporate Transactions & Securities Group at Alston & Bird and the head of Alston & Bird’s Financial Advisors Practice. Alston & Bird is regularly ranked by The American Lawyer and Corporate Control Alert as among the leading counsel to investment banks acting as financial advisors.
Kevin is a frequent author and speaker on M&A topics, including fairness opinions, the role of investment bankers and legal and regulatory developments relating to mergers and acquisitions. Kevin is a member of the Mergers, Acquisitions & Corporate Control Contests Committee of the New York City Bar, as well as the advisory boards of DealLawyers.com and the DealLawyers newsletter and a frequent contributor to the DealLawyers.com Blog. Kevin is a graduate of Rutgers University (JD) and the University of Michigan (MA and AB).
Kira Schwartz is Senior Vice President and Associate General Counsel at Allergan plc. She leads the legal team responsible for mergers and acquisitions, licensing transactions, alliance management, corporate governance and human resources support. Ms. Schwartz joined Forest Laboratories, Inc. in 2008 as Associate General Counsel and continued with Actavis plc following Actavis’ acquisition of Forest Laboratories. She led Actavis’ acquisition of Allergan, Inc. and the divestiture of the company’s generics business to Teva.
Prior to joining Forest Laboratories, Ms. Schwartz was Senior Corporate Counsel, Business Transactions, at Pfizer Inc. and a corporate associate at Cleary, Gottlieb, Steen & Hamilton LLP. Ms. Schwartz received a J.D. from Yale Law School and a B.A. in Economics from Tufts University.
Patrick J. Suehnholz is Chief Operating Officer of Investment Banking and Director of Investor Relations.
Mr. Suehnholz joined Greenhill in 2010 as a summer associate in the Firm’s corporate advisory group in New York. Since then, he has advised clients across a wide range of industries on a variety of M&A and corporate finance transactions while also performing various administrative roles in both Greenhill’s New York and Houston offices.
Prior to Greenhill, Patrick was an analyst in the Real Estate group at UBS Investment Bank.
Patrick received his B.A. and his M.B.A from Harvard University.
Paul Shim is a partner in the New York, NY office of Cleary Gottlieb Steen & Hamilton LLP. His practice focuses on public and private merger and acquisition transactions.
He also provides advice regarding governance matters and the fiduciary duties of officers and directors to corporations and their boards.
He repeatedly has been recognized by the business and legal press for his work on behalf of clients, including twice being named a “Dealmaker of the Year” by The American Lawyer.
Raymond Gietz, a partner of Weil since 1989, is a member of the Firm’s Mergers & Acquisitions practice. He represents buyers, sellers, boards of directors, committees of independent directors and financial advisors in connection with complex mergers and acquisitions transactions, including public and private companies, LBOs, asset sales and joint ventures. He regularly advises boards of directors and committees on defense, corporate governance and other matters. Mr. Gietz also has been involved in numerous proxy fights and other contests for corporate control.
Mr. Gietz’s representation involves a range of industries, including healthcare, financial services and steel.
Recent M&A transactions include advising:
Mr. Gietz has been recognized in Chambers USA, Legal 500 US, New York Super Lawyers and has been featured as a “Dealmaker” by The American Lawyer. He was also recognized for client service excellence by BTI Consulting Group in its 2012 BTI Client Service All-Stars survey.
Scott W. Golenbock is a partner in the New York office of Milbank, Tweed, Hadley & McCloy and a member of the firm’s Corporate Group.
Primary Focus & EXPERIENCE
Mr. Golenbock’s practice focuses on mergers and acquisitions and corporate and securities law matters, and he has been involved in negotiated and hostile acquisitions, cross-border transactions, divestitures, joint ventures, spin-offs, corporate restructurings and corporate governance matters. He has advised public and private companies in a variety of industries, including hospitality, gaming, retail, real estate, energy, financial services, education/publishing and technology, as well as financial sponsors.
Selected notable representations include:
Recognition & Accomplishments
Mr. Golenbock graduated magna cum laude from Princeton University. He received a J.D. from Yale Law School in 2005, where he served as a senior editor of The Yale Law Journal.
Mr. Golenbock is an Adjunct Professor at New York Law School, where he teaches a course on Mergers and Acquisitions.
Stephen M. Kotran is a partner in the Mergers and Acquisitions and Financial Institutions Groups at Sullivan & Cromwell LLP and a member of the firm’s Managing Partners Committee. He represents buyers, sellers, special committees of independent directors and financial advisors in connection with mergers and acquisitions transactions, including negotiated and hostile acquisitions of public companies, negotiated sales of private companies, subsidiaries and divisions, private equity transactions, leveraged buy-outs, formation of joint ventures and asset sales. In recent transactions, his clients have included Acosta, Inc., ADP, Inc., Bank of America Merrill Lynch, Barclays, China Oceanwide, Cytec Industries, Inc., Eastman Kodak Company, Evercore Partners, Goldman, Sachs & Co., ING Groep N.V., Ipsen, S.A., Orix, Inc., Platinum Underwriters Holdings, Ltd., Rothschild, Inc., Sprout Pharmaceuticals, Swiss Reinsurance Company Ltd., Wells Fargo Securities LLC and Western World Insurance Group.
Mr. Kotran graduated from Harvard College (A.B., 1985) and the University of Virginia Law School (J.D., 1990) where he was an Editor of the Virginia Law Review and a member of the Order of the Coif. From 1985-1986, Mr. Kotran served as a legislative assistant to U.S. Senator Daniel P. Moynihan (D-NY) and from 1990-1991 he served as a judicial clerk to the Hon. Edward R. Becker (U.S. Court of Appeals, Third Circuit). He has been consistently recognized as a leading M&A, private equity and insurance transactional lawyer by many widely referenced legal guides, including The Best Lawyers in America, Chambers, IFLR, Lawdragon, New York Super Lawyers, PLC and The US Legal 500. Mr. Kotran is a frequent faculty member on M&A panels for the American Bar Association, the Practising Law Institute, the New York City Bar Association and various other professional organizations. He is a lecturer in Law at Columbia Law School where he teaches a course on M&A transactions and also has guest lectured at numerous other law schools including Fordham, NYU, Stanford, U.Penn and UVa. He is a former co-chair of the Financial Advisors Task Force of the M&A Committee of the Business Law Section of the American Bar Association. He also serves on the M&A Advisory Board of the Practical Law Company.
Trevor Norwitz is a partner in the Corporate Department at Wachtell, Lipton, Rosen & Katz where he focuses primarily on mergers and acquisitions, corporate governance and securities law matters. He has advised a range of public and private entities in a variety of industries in connection with mergers, acquisitions, divestitures, hostile takeover bids and defenses, proxy contests, joint ventures, financing transactions and corporate governance matters.
Selected recent representations by Mr. Norwitz include: Whole Foods in its sale to Amazon.com and its response to shareholder activism; Medivation in its sale to Pfizer; Dollar Tree in its contested acquisition of Family Dollar Stores; eBay in connection with a proxy contest by Carl Icahn, and its spinoff of PayPal, Inc.; Creative Artists Agency LLP in connection with its restructuring and sale of a controlling interest to TPG Group; S&P Global (formerly McGraw Hill) in its sale of the McGraw Hill Education business to Apollo Advisers, its joint venture with CME Group to form S&P/Dow Jones Indices, and its acquisitions of SNL Financial and other companies; and numerous acquisitions for Ventas, Novartis and Danaher Corporation.
Mr. Norwitz teaches a course in Mergers and Acquisitions at Columbia University School of Law. He chairs the New York City Bar Committee on Mergers and Acquisitions and Corporate Control Contests, and the M&A Subcommittee of the International Bar Association Securities Committee, and is a member of the American Law Institute, and committees of the American Bar Association. He served as a member of an international advisory group to the South African government on company law reform. A regular speaker and panelist at professional conferences, he has chaired and participated in numerous continuing legal education programs and contributes regularly to professional publications on topics relating to M&A and corporate governance. Mr. Norwitz also chairs and serves on a number of non-profit boards of directors, and on the Advisory Board of the Robert L. Bernstein Institute of Human Rights at NYU Law School.
Born in Cape Town, South Africa, Mr. Norwitz received his Bachelor of Business Science with first class honors from the University of Cape Town in 1986. On a Rhodes Scholarship to Oxford University, he read law at Keble College, graduating with first class honors in 1989, and then completed an LL.M. at Columbia University in 1990. He joined the firm in 1994 and was named partner in 1998.
Wilson Chu is a partner in the Dallas office of McDermott Will & Emery LLP. His practice focuses on M&A, joint ventures, and other strategic transactions, as well as related corporate governance, for clients ranging from Fortune 500 serial acquirers to private equity funds to high-growth, high-profile technology companies in the United States and abroad. While he has experience in a wide range of industries, his practice is heavily-weighted in the technology and healthcare sectors (particularly, healthtech and fintech).
His representative M&A clients include:
Wilson created and continues to be the architect of the influential M&A Deal Points Studies published by the Market Trends Subcommittee (which he co-founded) of the ABA’s Mergers & Acquisitions Committee (for which he serves as Vice Chair). He is founding co-chair of the University of Texas Mergers & Acquisitions Institute, the country’s leading private company M&A conference, and the founding chair of the International Finance Law Review/Inter-Pacific Bar Association’s Asia M&A Forum in Hong Kong, Asia’s leading M&A law conference. Wilson is also an active leader in broad range of groundbreaking initiatives that promote the business case for diversity, including, Founder, NAPABA Partners Network, Founding Member, Selection Committee for NAPABA’s Best Lawyers Under 40, and Founding Co-Chair, Texas Minority Counsel Program.
Mr. Coats is a Partner of Riverstone, serving as General Counsel. He is based in New York.
Prior to joining Riverstone in April 2008, Mr. Coats was a Partner at Vinson & Elkins L.L.P., a law firm specializing in the energy sector. While at Vinson & Elkins, he focused on domestic and cross-border M&A work in the energy sector. Prior to joining Riverstone, Mr. Coats was outside counsel to Riverstone in several transactions including, among others, Niska Gas Storage, Frontier Drilling, Red Technology Alliance, and Phoenix Exploration Company.
He received his B.A. in Government from the University of Texas at Austin in 1993 and his J.D. from the University of Texas School of Law in 1997. Mr. Coats is licensed to practice law in the states of New York and Texas.
Mr. Goldberg is co-head of Davis Polk's global Mergers and Acquisitions Group. He advises companies around the globe on their most significant public or private mergers and acquisitions transactions and board level matters. His practice also encompasses a full spectrum of corporate, strategic, defensive and crisis assignments ranging from advising on activist situations or unsolicited bids, special committee assignments or board investigations or governance advice, to spinoffs, private equity investments and representing consortia in FinTech and other sectors.
Mr. Goldberg’s client representations include AgroAmerica, Amdocs, Citigroup, ExxonMobil, Heineken, IHS Markit, Morgan Stanley, Syngenta AG and the Williams Companies.
Mr. Goldberg is recognized as a leader in the legal industry:
He is consistently recognized as a leading M&A lawyer in various industry publications:
Stephen is an Assistant General Counsel at Pfizer, where he advises on all types of complex acquisition and disposition strategies and transactions, including taxable and tax-free mergers; spin-offs, carve-outs, cross-border M&A and financing transactions.
His recent deals include Pfizer's acquisition of gene therapy developer Bamboo Therapeutics Inc. and Anacor Pharmaceuticals Inc. Since joining Pfizer in 2010, Stephen has worked on over 75 strategic and financial transactions, including the company’s terminated merger with Allergan plc (2015-16), its $15 billion acquisition of Hospira, Inc. (2015) and the $17 billion tax-free spin-IPO and off of its Animal Health business into Zoetis Inc. (2013), among others. Prior to Pfizer, he practiced law at Milbank Tweed Hadley & McCloy LLP and Sidley Austin LLP.
Stephen is a graduate of William & Mary Law School, where he was a member of the William & Mary Law Review, and New York University (B.A., International Relations). He is a member of the New York State bar.